Dr. David Fajgenbaum

And so we've intentionally taken the approach of let's use AI and data to find the best uses for the best drugs possible.

so that we can move them forward so that way we aren't doing Hail Marys.

But the reality is, Latif, is that people are suffering all the time, and we are contacted all the time, and we want to help any way we can.

And we're going to be making our algorithms publicly available in about nine months' time.

But until then, we want to continue to improve them.

We feel this tremendous responsibility that once we share it, that it's out, right?

And so we're going to continue to improve it over the next nine to 12 months, but then we will share it.

So the intention will be for doctors and researchers to use it.

So that way they can come up with new areas for research.

They can think about it for their patients.

But the reality, I think, is that patients will also use it.

How do you use it?

Yeah, so we call it the matrix.

So it's an acronym.

Everything has to have an acronym in my life.

It's so it's ML aided therapeutic repurposing and extended uses matrix.

Repurposing R, I in, and then it gets a little sloppy then, extended.

We're using the X in extended for matrix uses.

Oh, okay.

Then Eustace.